Literature DB >> 31986891

MicroRNA-140-5p suppresses invasion and proliferation of glioma cells by targeting glutamate-ammonia ligase (GLUL).

R Zhang1, J C Zhu1, H Hu2, Q Y Lin3, W Shao3, T H Ji1,3.   

Abstract

Glutamine addiction is a major feature of glioma cells and plays an important role in its growth and proliferation. GLUL (glutamate-ammonia ligase), which catalyzes glutamate and ammonia to synthesize glutamine, plays a crucial role in tumor growth and proliferation. We attempt to determine a pathway that limits the growth of glioma by targeting GLUL and explore effective strategies blocking glutamine metabolism. We note that miRNAs mediate regulation of genes participating directly or indirectly in cancer cell metabolism. The regulatory roles of miRNAs on metabolic enzymes are widely discussed, however miRNAs regulation of glutamine metabolism by targeting GLUL in glioma has not yet been reported. Here, we examined both the expression and functions of GLUL in glioma cells. Findings indicated that the expression of GLUL was upregulated in high-grade compared to low-grade glioma cells. Knockdown of GLUL effectively inhibited proliferation, migration and invasion of glioma cells in vitro. Bioinformatics analyses, as well as dual-luciferase reporter assays, revealed that miR-140-5p bound to GLUL mRNA at the 3'-UTR location. Furthermore, the proliferation, migration and invasion of glioma cells were also repressed by miR-140-5p. Overall, these results showed that miR-140-5p exerted its inhibitory effects on proliferation, migration and invasion in glioma cells through downregulating GLUL. Thus, the miR-140-5p/GLUL axis may function as a potential target for glioma treatment.

Entities:  

Year:  2020        PMID: 31986891     DOI: 10.4149/neo_2020_190514N432

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  3 in total

1.  MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway.

Authors:  Zhilai Lin; Jianguang Pan; Lei Chen; Xinhang Wang; Yuhua Chen
Journal:  Onco Targets Ther       Date:  2020-08-17       Impact factor: 4.147

Review 2.  Non-Coding RNAs as Key Regulators of Glutaminolysis in Cancer.

Authors:  Yunuen Ortiz-Pedraza; J Omar Muñoz-Bello; Leslie Olmedo-Nieva; Adriana Contreras-Paredes; Imelda Martínez-Ramírez; Elizabeth Langley; Marcela Lizano
Journal:  Int J Mol Sci       Date:  2020-04-20       Impact factor: 5.923

3.  miR-140 inhibits osteosarcoma progression by impairing USP22-mediated LSD1 stabilization and promoting p21 expression.

Authors:  Wei Liu; Dunwei Wang; Lidi Liu; Lin Wang; Ming Yan
Journal:  Mol Ther Nucleic Acids       Date:  2021-02-03       Impact factor: 8.886

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.